Pil AIDS Three in One

Various medicine were created although being not yet proven could destroy the HIV virus (Human Immunodeficiency Virus). Like that was carried out by a pair of the manufacturer's companies of the AIDS medicine, Bristol-Myers Squibb Co. and Gilead Sciences Inc. Second this company just announced his collaboration in the development of the first pill in the world for the AIDS.

Must be known that at this time, the best medical treatment method the AIDS required each one of his patients to drink two to three pills a day. Moreover approximately in the last 10 years, many patients who must be willing to swallow 25 to 30 pills per the day in order to be able to continue to remain. Certainly, for a patient, really was difficult to cut this medical treatment schedule. Even, if losing several doses could cause the virus bermutasi and to resisten against the medicine. Therefore, Bristol-Myers Squibb Co. and Gilead Sciences Inc. tried to carry out the breakthrough. Constructively the co-operation at the same time marketed the single pill results of the combination of three pills that for a long time have been used as medical treatment of AIDS. briefly, they will make an effort to produce the AIDS pill three in one.

"Put the intensity of three pills into one pill was the great discovery," said Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases to Associated Press. The uniqueness, two among three pills came from the different class of AIDS medicine. The Sustiva pill the Bristol production- Myers Squibb will also be put in the combination pill. Two other was artificial Foster City Viread AIDS medicine and Emtriva. The two last medicines came from the same class of AIDS medicine. These pills could hinder the process of virus multiplying of AIDS. Sedangkan Sustiva of coming from the different medicine class, his function, attacked the virus in his circulation.

"This was the first time of two companies with the competitive product each other co-operated," said Dr. Michael Saag, the Director of the Center AIDS in University of Alabama, Birmingham, England. "This pill was a supporter" of the "life" of the "patient and many doctors urged his existence for more than one decade," he added. Must be known, to get the three medicines above, a sufferer the AIDS must spend USD money 900 (around Rp 8.3 million) until USD 1,000 (around Rp 9.3 million) per the month. But, the price for the pill produced by the combination was still not determined